Search

Searching. Please wait…

Pembrolizumab combined with lenalidomide and low-dose dexamethasone for relapsed or refractory multiple myeloma: phase I KEYNOTE-023 study

 Fuente: British Journal of Haematology, 2019, 186(5), e117-e121

 Publisher: Blackwell Publishing Ltd

 Year of publication: 2019

 No. of pages: 5

 Publication type: Article

 DOI: 10.1111/bjh.15946

 ISSN: 0007-1048,1365-2141

 Publication Url: https://doi.org/10.1111/bjh.15946

Authorship

MATEOS, MARIA VICTORIA

ORLOWSKI, ROBERT Z.

RODRÍGUEZ OTERO, PAULA

REECE, DONNA

MOREAU, PHILIPPE

MUNSHI, NIKHIL

AVIGAN, DAVID E.

SIEGEL, DAVID S.

GHORI, RAZI

FAROOQUI, MOHAMMED Z. H.

MARINELLO, PATRICIA

SAN MIGUEL, JESÚS